TransMedics Group Inc (TMDX)

TransMedics Group, Inc. is a commercial-stage medical technology company focused on improving organ transplant therapy for patients with end-stage organ failure in the United States and abroad. The company’s core platform is the Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system designed to maintain donor organs in near-physiologic conditions outside the body. Its product suite includes OCS LUNG for preserving standard-criteria donor lungs for double-lung transplantation, OCS Heart for preserving donor hearts and supporting ex vivo reanimation and functional monitoring, and OCS Liver for donor liver preservation. TransMedics also developed a national OCS program for outsourced organ retrieval and provides organ management and logistics services, including aviation and ground transportation coordination. Founded in 1998, the company is headquartered in Andover, Massachusetts.

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.